Summary
Acute rheumatic fever (ARF) is an inflammatory sequela involving the heart, joints, skin, and central nervous system (CNS) that occurs two to four weeks after an untreated group A β‑hemolytic streptococcal infection (GAS). The pathogenic mechanisms that cause rheumatic fever are not completely understood, but molecular mimicry between streptococcal M protein and human cardiac myosin proteins is thought to play a role. Because of the structural similarities between the two proteins, antibodies and T cells activated to respond to streptococcal proteins also react with the human proteins, causing tissue injury and inflammation. In addition to nonspecific symptoms (e.g., fever, malaise, and fatigue), patients present with symptoms involving the heart (carditis or valvulitis), joints (migratory polyarthritis), skin (subcutaneous nodules, erythema marginatum), and/or CNS (Sydenham chorea). The diagnosis of ARF is primarily clinical and based on the Jones criteria. Diagnostic evaluation in ARF typically shows elevated inflammatory markers, positive antistreptococcal antibodies, and valvular damage on echocardiogram. Treatment of ARF includes antibiotic therapy for GAS eradication, symptom-based treatment (e.g., for arthritis), and management of associated complications, which may include progressive, permanent damage to the heart valves (especially the mitral valve), resulting in chronic rheumatic heart disease (RHD). Long-term antibiotic prophylaxis and monitoring are recommended in all patients with ARF and RHD to prevent ARF recurrence and RHD progression.
© AMBOSS
Definitions
- Acute rheumatic fever: (ARF): delayed inflammatory complication of group A β‑hemolytic streptococcal infection; usually occurs within 1–5 weeks after the acute infection [1][2]
- Rheumatic carditis: a manifestation of ARF that includes acute pancarditis and/or valvulitis [3]
- Rheumatic heart disease (RHD): chronic cardiac valvular or muscle damage as a complication of ARF [1][3]
Epidemiology
- Peak incidence: 5–15 years of age [1][3]
- Prevalence: more common in resource-limited countries [1]
Epidemiological data refers to the US, unless otherwise specified.
Etiology
Previous infection with group A β‑hemolytic streptococcus (GAS), also referred to as Streptococcus pyogenes [1]
- Usually acute tonsillitis or pharyngitis (“strep throat”)
- May occur after GAS infections of the skin (e.g., erysipelas, impetigo, cellulitis) but less common than poststreptococcal glomerulonephritis
Pathophysiology
- The exact pathogenesis is not yet entirely understood.
- Most commonly accepted mechanism involves the following: acute tonsillitis/pharyngitis caused by GAS without antibiotic treatment → development of antibodies against streptococcal M protein → cross-reaction of antibodies with nerve and myocardial proteins (most commonly myosins) due to molecular mimicry → type II hypersensitivity reaction → acute inflammatory sequela [4][5]
Pathology
-
Myocardial findings [6][7]
-
Aschoff bodies
- Granuloma of rheumatic inflammation
- Central area of fibrinoid necrosis
- Surrounded by characteristic multinucleated giant cells (Aschoff cells) and other inflammatory cells (mononuclear cells, plasma cells, and T lymphocytes) due to a type IV hypersensitivity reaction.
-
Anitschkow cells
- Cardiac histiocytes (mononuclear cells) appearing in Aschoff bodies
- Large and elongated cells
- Longitudinal section: ovoid nucleus containing wavy, caterpillar-like bar of chromatin (caterpillar cell)
- Transverse section: owl-eye appearance
-
Aschoff bodies
Photomicrograph of a myocardial tissue specimen (H&E stain; high magnification)
A collagenous nodule (green overlay) is seen within the myocardial tissue. The nodule contains a loose lymphoplasmacytic infiltrate and large eosinophilic cells with an ovoid nucleus (Anitschkow cells, arrowheads). Anitschkow cells are thought to be histiocytes.
These nodules, referred to as “Aschoff bodies,” are thought to represent myocardial granulomas, which are typically found in rheumatic heart disease.
Source: “Aschoff Body in Rheumatic Myocarditis” by Ed Uthman, Flickr, licensed under CC BY-SA 2.0. The supplementary image with overlays of relevant areas was adapted from the image mentioned above and licensed under CC BY-SA 2.0.
Clinical features
Features of ARF usually manifest within 1–5 weeks following a GAS infection. Sydenham chorea typically manifest later (i.e., 1–8 months after of the initial infection). [2]
- Constitutional symptoms: : fever, malaise, fatigue
- Joints: migratory polyarthritis
-
Heart
- Pancarditis (endocarditis, myocarditis, and pericarditis)
-
Valvular lesions: most commonly on high-pressure valves
-
Mitral valve (∼ 65% of cases)
- Early mitral regurgitation or prolapse
- Late mitral stenosis: Rheumatic fever is the most frequent cause of mitral stenosis.
- Mixed mitral stenosis/regurgitation
-
Aortic valve (∼ 25% of cases)
- Aortic regurgitation
- Aortic stenosis (late manifestation)
- Tricuspid valve (∼ 10% of cases)
-
Mitral valve (∼ 65% of cases)
- Dilated cardiomyopathy due to severe valvular disease, myocarditis
-
CNS: Sydenham chorea (involuntary, irregular, nonrepetitive movements of the limbs, neck, head, and/or face) [8]
- ♀ > ♂ (∼ 2:1)
- Most common cause of acute chorea in children in the US
- Occurs 1–8 months after the inciting infection [2]
- Clinical features
- Sometimes asymmetrical or confined to one side (hemichorea)
-
Additional motor symptoms (e.g., ballismus, muscle weakness) and speech disorders (slurred or “jerky” speech)
- Milkmaid grip: characterized by the inability to maintain muscle contraction in the hands → intermittent loss of contraction results in alternating squeeze and release of grip ("milking")
- Choreic hand: characterized by intermittent wrist flexion with extension of the digits (“spooning” of the hand)
- Neuropsychiatric symptoms (e.g., inappropriate laughing/crying, agitation, anxiety, apathy, obsessive-compulsive behavior)
- Pathophysiology: Streptococcal antigens lead to antibody production → antibodies cross-react with structures of the basal ganglia (particularly the striatum) and cortical structures → reversible dysfunction of cortical and striatal circuits
-
Skin
- Subcutaneous nodules
-
Erythema marginatum: centrifugally expanding pink or light red rash with a well-defined outer border and central clearing.
- Painless and nonpruritic
- Location: The trunk and limbs are affected; the face is spared. May rapidly appear and disappear at different locations. [4][9]
- Differential diagnosis: For details, see “Overview of annular skin lesions.”
Rheumatic heart disease tends to involve the high-pressure valves (i.e., the mitral and aortic valves).
Valvular lesions sometimes do not manifest until pregnancy, when blood volume is increased. [1]
The symptoms of acute rheumatic fever can be remembered by reading the JONES criteria (see “Diagnostics” below) as an acronym that replaces the “o” with a heart: J = Joints, ♥ = Pancarditis, N = Nodules, E = Erythema marginatum, S = Sydenham chorea
Solitary subcutaneous, erythematous, warm and tender protuberances are visible on the left shoulder.
In conjunction with flu-like symptoms, ankle swelling, and an elevated antistreptolysin-O (ASO) titer, these skin findings indicate rheumatic fever.
Source: “Figure 1, in: Acute Rheumatic Fever: A Review of Essential Cutaneous and Histological Findings” by M. A. Heard, M. C. Green, M. Royer, Cureus, licensed under CC BY 4.0.
Left upper arm of a child diagnosed with acute rheumatic fever (ARF)
Erythematous plaques with areas of central clearing are visible on the ventral aspect of the forearm.
This is characteristic of erythema marginatum, the characteristic annular erythema occuring in 10% of attacks of acute rheumatic fever in children, caused by group A streptococcus.
Source: “Erythema marginatum” by Adsie, Wikimedia Commons, licensed under CC BY-SA 4.0. Modifications: image has been cropped.
Diagnosis
General principles [1][4][9]
- Patients should be evaluated for evidence of a preceding GAS infection via throat culture, antigen, or antibody test.
- ARF is diagnosed using the revised Jones criteria.
- All patients with suspected or confirmed ARF require a cardiac workup.
In settings where testing for GAS infection is limited, consider empirical treatment of ARF in patients with suggestive clinical features even in the absence of confirmed GAS infection. [1]
Revised Jones criteria [1][2][9]
- Diagnostic criteria for patients with laboratory findings of a preceding GAS infection
- Initial episode of ARF: two major criteria or one major plus two minor criteria
- Recurrent ARF: either the same as for an initial episode of ARF or the presence of three minor criteria
| Revised Jones criteria for the diagnosis of ARF [1][2][9] | ||
|---|---|---|
| Low-risk populations | Moderate- to high-risk populations | |
| Major criteria |
|
|
| Minor criteria |
|
|
Routine laboratory studies [9][10]
Initial laboratory findings typically show nonspecific signs of infection.
- Complete blood cell count: may show leukocytosis and/or anemia [9]
-
Acute phase reactants [9]
- CRP: elevated, typically ≥ 3.0 mg/dL
- ESR: elevated, typically ≥ 60 mm/hour
Confirmation of GAS infection [9][10]
- Used to rule out differential diagnoses
- Any of the following test results can confirm recent GAS infection:
- Tests showing elevated or rising antibodies
- ↑ Antistreptolysin O titer (ASO)
- ↑ Antistreptococcal DNAse B titer (ADB)
- Positive throat culture
- Positive rapid GAS carbohydrate antigen detection test
- Tests showing elevated or rising antibodies
- False positives are possible due to colonization of GAS in the upper respiratory tract.
- For more information on the diagnosis of GAS pharyngitis, see "Acute tonsillitis."
Assessment for cardiac involvement [1][3][5]
Obtain an ECG and echocardiography in all patients with confirmed or suspected ARF.
| Cardiac findings in ARF and RHD [1][3][5] | |
|---|---|
| Modality | Characteristic findings |
| ECG [11] |
|
| Echocardiography [5][12] |
|
| Chest x-ray [3] |
|
Assessment for neurological involvement [13][14]
- The diagnosis of Sydenham chorea is based on clinical and laboratory findings.
-
Neuroimaging (MRI or CT brain)
- Not routinely indicated but may be performed to exclude other forms of chorea
- Findings are nonspecific and variable.
- Lumbar puncture: not routinely indicated; may be performed to exclude other disorders
- Echocardiography should be obtained in all patients with Sydenham chorea because concurrent cardiac involvement is common. [11]
12-lead ECG (paper speed: 25 mm/s)
– Normal sinus rhythm
– Heart rate: ∼80/min
– Normal axis
– PR interval: ∼300 ms
The PR interval >200 ms indicates first-degree atrioventricular block.
Our great thanks to Thomas Vahldieck, MD, for kindly providing this case.
15-lead ECG (paper speed: 25 mm/s)
– Irregularly irregular rhythm
– Atrial rate ~70/min, ventricular rate ~40/min
– Left axis deviation (LAD): R > S in lead I (+), R < S in II and aVF (-)
– Right bundle branch block (RBBB): QRS is widened (∼150 ms) with RBBB morphology (green overlay).
– Left anterior fascicular block (LAD and qR in aVL)
– Regular P waves throughout (red overlay), with intermittent nonconducted P waves (circled P)
– AV conduction ratio (P:QRS): initially 3:2, then 2:1
– PR interval: prolonged (∼240 ms) but constant in the conducted beats
The intermittent nonconducted P waves, with constant PR in the conducted beats, indicate Mobitz II second-degree atrioventricular block (which may have a regular conduction ratio or be completely irregular). The combination of RBBB and left anterior fascicular block represents a bifascicular block.
Source: “2ndDegreeType2” by James Heilmann, MD, Wikimedia Commons, licensed under CC BY-SA 3.0. Modifications: removed in-image shadow. The supplementary image with overlays of relevant areas was adapted from the image mentioned above and licensed under CC BY-SA 3.0.
Rhythm strip ECG (paper speed: 25 mm/s)
– Atrial rate ∼100/min
– Ventricular rate ~40/min (escape rhythm)
– RR intervals and PP intervals are regular.
– Atrioventricular (AV) dissociation: P waves (red overlay) and QRS complexes (green overlay) have regular but unrelated rhythms because there is no conduction between atria and ventricles, resulting in some P waves being completely or partially buried in QRS complexes (6th P wave) or T waves (4th and 9th P waves).
AV dissociation with bradycardia is characteristic of third-degree AV block (complete heart block).
Source: "Rhythm strip showing third degree heart block.", MoodyGroove, Wikimedia Commons licensed under Public Domain
X-ray chest (PA view)
A convexity between the moguls produced by the main pulmonary artery (PA) and left ventricle (LV) suggests enlargement of the left atrial appendage (LAA; normal configuration indicated by dashed line). Breast shadow opacification (green overlay) simulates parenchymal airspace disease.
AA: aortic arch
Source: © IMPP
Treatment
Management of ARF involves antibiotics to treat acute GAS infection, supportive management for fever and/or arthritis, management of associated complications, and long-term antibiotic prophylaxis to prevent ARF recurrence and RHD progression.
GAS eradication [1][2][10][15]
The following antibiotics are recommended for the eradication of GAS after pharyngitis.
- First-line: oral penicillin V or IM penicillin G [1][2][10]
-
In patients with penicillin allergy, use:
- Cephalosporins (hypersensitivity without anaphylaxis)
- OR macrolides (severe hypersensitivity to beta-lactam antibiotics) [1]
- For dosages, see “Recommended antibiotic regimens for acute GAS pharyngitis.”
There is insufficient evidence to recommend specific antibiotics for the eradication of GAS and prevention of ARF after skin and soft tissue infections; follow standard recommendations for antibiotic therapy for soft tissue infection. [1]
Symptomatic treatment of arthritis and fever [10][11]
-
ARF not confirmed [11]
- Acetaminophen is preferred.
- For dosages, see “Oral analgesics.”
-
ARF confirmed
-
NSAIDs
- Naproxen or ibuprofen are preferred for children. [11]
- Aspirin ; use with caution in children due to the risk of Reye syndrome. [10][11]
-
Titrate dosage based on treatment response. [10][11]
- Use the lowest effective dose for the shortest duration.
- No symptomatic improvement after 2–3 days of treatment: Consider alternative diagnoses.
- Symptoms worsen after dose reduction: Resume higher dose for a short period.
- Total duration of treatment: 1–12 weeks [10][11]
- In patients with arthritis, a period of activity restriction may be indicated; encourage ambulation once pain and joint tenderness improve.
-
NSAIDs
Anti-inflammatory drugs relieve ARF symptoms. There is insufficient evidence to recommend their use to prevent progression to RHD. [1][10]
Management of complications
Rheumatic heart disease
Screening for RHD [1]
Consider in populations or areas with a moderate or high risk of rheumatic heart disease. [1]
- Modality: echocardiography
- Recommended groups:
- Pregnant individuals
- Children aged 5–19 years
- Screening frequency: not clearly defined; tailor to local protocols and available resources.
Management of RHD [3][10]
- Initiate antibiotic prophylaxis to prevent ARF recurrence.
- Refer all patients with carditis or RHD to cardiology.
- Management is focused on associated complications, e.g.:
- Treatment of heart failure [16]
- Anticoagulation for atrial fibrillation
- Endocarditis prophylaxis and early aggressive treatment of endocarditis
- Valvuloplasty and prosthetic heart valve replacement
- All patients require long-term follow-up with regular echocardiography.
Sydenham chorea [10][11][17]
In the majority of cases, Sydenham chorea is self-limited, with most patients seeing an improvement within a few weeks and nearly all patients fully recovered by six months.
-
Supportive therapy: indicated for all patients; may be the only treatment required in mild disease
- Rest in a calm environment
- Avoidance of overstimulation
- Patient and caregiver education about the condition
-
Pharmacotherapy
- Consider for patients with difficulties performing activities of daily living.
- Options include carbamazepine and valproic acid. [4][18]
- Additional treatment options for patients with persistent symptoms or refractory severe disease include:
- Prednisone
- Risperidone
- IVIG
- Plasmapheresis
Prevention of ARF recurrence and RHD progression
General principles [1][2][3]
- On completion of antibiotic therapy for GAS eradication, start antibotic prophylaxis to prevent ARF recurrence in all patients. [1][2][3]
- Educate patients on early recognition of symptoms and the importance of adhering to prophylaxis.
- Emphasize the importance of dental care and regular dental checkups. [3]
- GAS infection of close or household contacts should be treated promptly. [10]
Long-term antibiotic prophylaxis to prevent ARF recurrence is essential; ARF can recur even after an asymptomatic or appropriately treated symptomatic GAS infection. [1][2][3]
Long-term antibiotic prophylaxis [1][2][19]
- Indication: all patients with ARF or RHD
- Timing: immediately after completion of antibiotics for ARF
-
Agents
- First-line: IM penicillin G benzathine every 4 weeks (off-label) [1][2][19]
- Alternative: oral penicillin V (off-label for children < 12 years) [1][20]
- Patients with confirmed penicillin allergy : sulfadiazine or oral macrolides [1][2][10]
-
Duration: Use the longest applicable course of treatment based on patient factors. [10][19]
- Possible ARF : 12 months [2][3][10]
- Rheumatic fever without carditis: 5 years or until the patient reaches 21 years of age [2][3]
- Rheumatic fever with carditis and without residual heart disease: 10 years or until the patient reaches 21 years of age
- Rheumatic fever with carditis and permanent valvular heart defects: 10 years or until the patient reaches 40 years of age [2][3]
- Continue antibiotic prophylaxis beyond the above durations in patients at high risk of GAS infection (e.g., frequent contact with children). [2]
Adherence to long-term antibiotic prophylaxis can be challenging. Address risk factors for poor adherence and, for patients who experience pain from injections, mix local anesthetic with the injectable solution to reduce pain. [1]
Prognosis
Cardiac involvement is the most important prognostic factor.
- Early death from rheumatic fever is usually due to myocarditis rather than valvular defects.
- Patients with a history of carditis (and possible post-inflammatory scarring and calcification) during an initial rheumatic fever episode are at high risk of developing valvular heart defects with recurrent episodes → rheumatic heart disease
Prevention
Initiate antibiotic treatment promptly for GAS infections, e.g.: [1][15][17][19]
- Antibiotics for GAS tonsillopharyngitis (e.g., with penicillin V)
- Antibiotic therapy for skin and soft tissue infection
External Resources
- 2024 CDC Clinical Guidance for Acute Rheumatic Fever
- 2024 WHO Guideline on the Prevention and Diagnosis of Rheumatic Fever and Rheumatic Heart Disease
- 2020 (reviewed in 2022) RHD Australia (ARF/RHD writing group) Guidelines for Prevention, Diagnosis and Management of ARF/RHD
- 2015 Scientific Statement from the AHA on the Revision of the Jones Criteria
References
- "WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease". https://www.who.int/publications/b/59223. [2024-10-01]
- Committee on Infectious Disease, American Academy of Pediatrics. "Red Book: 2024-2027 Report of the Committee on Infectious Diseases, 33rd Edition". American Academy of Pediatrics. (2024). ISBN: 9781610027373
- Kumar RK, Antunes MJ, Beaton A, et al. "Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association". Circulation. 142(20). (2020)
- Carapetis JR, Beaton A, Cunningham MW, et al. "Acute rheumatic fever and rheumatic heart disease". Nat Rev Dis Primers. 2(1). (2016)
- Pandian NG, Kim JK, Arias-Godinez JA, et al. "Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography". J Am Soc Echocardiogr. 36(1). :3-28. (2023)
- "Sydenham Chorea". https://rarediseases.org/rare-diseases/sydenham-chorea/. [2020-09-01]
- Gewitz MH, Baltimore RS, Tani LY, et al. "Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.". Circulation. 131(20). :1806-18. (2015)
- Lahiri S, Sanyahumbi A. "Acute Rheumatic Fever". Pediatrics In Review. 42(5). :221-232. (2021)
- "The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease (3.2 edition, March 2022)". https://web.archive.org/web/20241115170439/https://www.rhdaustralia.org.au/system/files/fileuploads/arf_rhd_guidelines_3.2_edition_march_2022.pdf. [2022-03-01]
- Rwebembera J, Marangou J, Mwita JC, et al. "2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease". Nat Rev Cardiol. 21(4). :250-263. (2023)
- Risavi BL, Iszkula E, Yost B. "Sydenham's Chorea.". J Emerg Med. 56(6). :e119-e121. (2019)
- Zomorrodi A, Wald ER. "Sydenham's chorea in western Pennsylvania.". Pediatrics. 117(4). :e675-9. (2006)
- FRASER WJ, HAFFEJEE Z, COOPER K. "Rheumatic Aschoff nodules revisited: an immunohistological reappraisal of the cellular component". Histopathology. 27(5). :457-461. (1995)
- Roberts S, Kosanke S, Terrence Dunn S, et al. "Pathogenic Mechanisms in Rheumatic Carditis: Focus on Valvular Endothelium". J Infect Dis. 183(3). :507-511. (2001)
- Karthikeyan G, Guilherme L. "Acute rheumatic fever.". Lancet (London, England). 392(10142). :161-174. (2018)
- Gerber MA, Baltimore RS, Eaton CB, et al. "Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis". Circulation. 119(11). :1541-1551. (2009)
- Shulman et al. "Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 55(10). :e86–e102. (2012)
- Anderson NE, Barber PA. "Limbic encephalitis – a review". J Clin Neurosci. 15(9). :961-971. (2008)
- Dougherty S, Okello E, Mwangi J, Kumar RK. "Rheumatic Heart Disease". J Am Coll Cardiol. 81(1). :81-94. (2023)
- Dean SL, Singer HS. "Treatment of Sydenham's Chorea: A Review of the Current Evidence". Tremor Other Hyperkinet Mov (N Y). 7. :456. (2017)